Entrada Therapeutics, Inc. (TRDA) Tops Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts TRDA Hot Sheet
Join SI Premium – FREE
Entrada Therapeutics, Inc. (NASDAQ: TRDA) reported Q4 EPS of ($0.94), $0.04 better than the analyst estimate of ($0.98). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $5.81 million.
For earnings history and earnings-related data on Entrada Therapeutics, Inc. (TRDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
- ZTO Express (ZTO) Tops Q2 EPS by 379c
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
